Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer

NCT04669132 is registered in ClinicalTrials.gov with Instituto Brasileiro de Controle do Cancer as lead sponsor.

NCT NCT04669132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04669132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer
Lead sponsor
Instituto Brasileiro de Controle do Cancer
Phase
Phase 2
Overall status
Completed
Start date
December 17, 2020
Completion date
January 17, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nausea post chemotherapy